Summary
The global Opioid Induced Constipation (OIC) Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on Drug Type, the report describes major products type share of regional market. Products mentioned as follows:
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Drug Type
1.2.1.1 Lubiprostone
1.2.1.2 Methyl Naltrexone Bromide
1.2.1.3 Naldemedine
1.2.1.4 Alvimopan
1.2.1.5 Others
1.2.2 by Application
1.2.2.1 Hospital Pharmacies
1.2.2.2 Retail Pharmacies
1.2.2.3 Online Pharmacies
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Lubiprostone Market, 2013-2018
4.1.2 Methyl Naltrexone Bromide Market, 2013-2018
4.1.3 Naldemedine Market, 2013-2018
4.1.4 Alvimopan Market, 2013-2018
4.1.5 Others Market, 2013-2018
4.2 Market Forecast
4.2.1 Lubiprostone Market Forecast, 2019-2024
4.2.2 Methyl Naltrexone Bromide Market Forecast, 2019-2024
4.2.3 Naldemedine Market Forecast, 2019-2024
4.2.4 Alvimopan Market Forecast, 2019-2024
4.2.5 Others Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Pharmacies Market, 2013-2018
5.1.2 Retail Pharmacies Market, 2013-2018
5.1.3 Online Pharmacies Market, 2013-2018
5.2 Market Forecast
5.2.1 Hospital Pharmacies Market Forecast, 2019-2024
5.2.2 Retail Pharmacies Market Forecast, 2019-2024
5.2.3 Online Pharmacies Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Ironwood Pharmaceuticals Inc
8.2 Daiichi Sankyo Co Ltd
8.3 Pfizer
8.4 Progenics Pharmaceuticals Inc
8.5 Shionogi & Co., Ltd
8.6 Allergan Plc
8.7 Nektar Therapeutics
8.8 Purdue Pharma
8.9 S.L.A. Pharma AG
8.10 Mundipharma International Limited
8.11 Ono Pharmaceutical Co., Ltd
8.12 Takeda Pharmaceutical Company Limited
8.13 Theravance Biopharma Inc
8.14 Valeant Pharmaceuticals International
8.15 Cosmo Pharmaceuticals SA
8.16 Daewoong Pharmaceutical
8.17 C.B. Fleet Company
8.18 Sucampo Pharmaceuticals
9 Conclusion
Table Product Specifications of Opioid Induced Constipation (OIC) Drugs
Table Products Segment of Opioid Induced Constipation (OIC) Drugs
Table Lubiprostone Overview
Table Methyl Naltrexone Bromide Overview
Table Naldemedine Overview
Table Alvimopan Overview
Table Others Overview
Table Global Opioid Induced Constipation (OIC) Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Opioid Induced Constipation (OIC) Drugs
Table Hospital Pharmacies Overview
Table Retail Pharmacies Overview
Table Online Pharmacies Overview
Table Global Opioid Induced Constipation (OIC) Drugs Market by Application, 2011-2022 (USD Million)
Table Global Opioid Induced Constipation (OIC) Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Opioid Induced Constipation (OIC) Drugs
Table Market Dynamics
Table Policy of Opioid Induced Constipation (OIC) Drugs
Table GDP of Major Countries
Table Lubiprostone CAGR by Revenue and Volume, 2012-2018
Table Methyl Naltrexone Bromide CAGR by Revenue and Volume, 2012-2018
Table Naldemedine CAGR by Revenue and Volume, 2012-2018
Table Alvimopan CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Lubiprostone CAGR by Revenue and Volume, 2012-2024
Table Methyl Naltrexone Bromide CAGR by Revenue and Volume, 2012-2024
Table Naldemedine CAGR by Revenue and Volume, 2012-2024
Table Alvimopan CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Hospital Pharmacies CAGR by Revenue and Volume, 2012-2018
Table Retail Pharmacies CAGR by Revenue and Volume, 2012-2018
Table Online Pharmacies CAGR by Revenue and Volume, 2012-2018
Table Global Opioid Induced Constipation (OIC) Drugs Market by Vendors, 2012-2018 (USD Million)
Table Global Opioid Induced Constipation (OIC) Drugs Market by Vendors, 2012-2018 (in Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Market Share by Vendors, 2012-2018 (USD Million)
Table Global Opioid Induced Constipation (OIC) Drugs Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Ironwood Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Ironwood Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Co Ltd Profile List
Table Microecological Modulator Operating Data of Daiichi Sankyo Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shionogi & Co., Ltd Profile List
Table Microecological Modulator Operating Data of Shionogi & Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Plc Profile List
Table Microecological Modulator Operating Data of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nektar Therapeutics Profile List
Table Microecological Modulator Operating Data of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Purdue Pharma Profile List
Table Microecological Modulator Operating Data of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table S.L.A. Pharma AG Profile List
Table Microecological Modulator Operating Data of S.L.A. Pharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mundipharma International Limited Profile List
Table Microecological Modulator Operating Data of Mundipharma International Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd Profile List
Table Microecological Modulator Operating Data of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited Profile List
Table Microecological Modulator Operating Data of Takeda Pharmaceutical Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Theravance Biopharma Inc Profile List
Table Microecological Modulator Operating Data of Theravance Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Profile List
Table Microecological Modulator Operating Data of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals SA Profile List
Table Microecological Modulator Operating Data of Cosmo Pharmaceuticals SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daewoong Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Daewoong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table C.B. Fleet Company Profile List
Table Microecological Modulator Operating Data of C.B. Fleet Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sucampo Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Opioid Induced Constipation (OIC) Drugs Picture
Figure Industry Chain Structure of Opioid Induced Constipation (OIC) Drugs
Figure SWOT of Opioid Induced Constipation (OIC) Drugs
Figure Lubiprostone Market Size and Growth, 2012-2018 (USD Million)
Figure Lubiprostone Market Size and Growth, 2012-2018 (in Volume)
Figure Methyl Naltrexone Bromide Market Size and Growth, 2012-2018 (USD Million)
Figure Methyl Naltrexone Bromide Market Size and Growth, 2012-2018 (in Volume)
Figure Naldemedine Market Size and Growth, 2012-2018 (USD Million)
Figure Naldemedine Market Size and Growth, 2012-2018 (in Volume)
Figure Alvimopan Market Size and Growth, 2012-2018 (USD Million)
Figure Alvimopan Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Figure Lubiprostone Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Lubiprostone Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Methyl Naltrexone Bromide Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Methyl Naltrexone Bromide Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Naldemedine Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Naldemedine Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Alvimopan Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Alvimopan Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Others Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Others Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Hospital Pharmacies Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Retail Pharmacies Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Online Pharmacies Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Opioid Induced Constipation (OIC) Drugs Market Concentration by Region
Figure Marketing Channels Overview
